Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Keep Inspiring

Don’t let your disease define you

Breaking Down the Implications of Calquence Combination Therapy in MCL

February 13th 2025, 2:00pm

Video

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in previously untreated mantle cell lymphoma.

FDA Approval of Calquence Combo Brings Optimism in MCL

February 11th 2025, 2:00pm

Article

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL.

FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL

February 5th 2025, 8:00pm

Article

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor approved for first line therapy.

Breaking Down Cancer Therapies Approved by the FDA in January 2025

February 3rd 2025, 4:00pm

Article

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

FDA Approves Calquence Combo for Mantle Cell Lymphoma

January 16th 2025, 11:17pm

Article

The Food and Drug Administration has granted traditional approval to Calquence with bendamustine and Rituxan for some patients with MCL.

Tecartus After Outpatient Lymphodepletion Safe, Effective in B-ALL and MCL

December 16th 2024, 4:00pm

Article

Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic leukemia and mantle cell lymphoma.

Survival Outcomes Not Improved With Autologous Stem Cell Transplant in MCL

December 11th 2024, 1:11am

Article

Autologous stem cell transplant plus Rituxan did not improve survival outcomes in certain patients with mantle cell lymphoma compared with Rituxan alone.

Heart Risk May Occur Less With Some BTK Inhibitors in B-Cell Blood Cancers

December 9th 2024, 11:00pm

Article

In patients with certain B-cell blood cancers, heart-related side effects may occur less after receiving second-generation BTK inhibitors.

Parenting and Cancer: How Much Do Kids Need to Know?

November 26th 2024, 10:00pm

Article

Musician Danielia Cotton and her partner, attorney Sam Roberts, discuss how much they’ve shared with their daughter about their cancer journeys.

Columvi Shows High Response Rates and Safety in R/R Mantle Cell Lymphoma

November 19th 2024, 2:00pm

Article

Treatment with Columvi showed a manageable safety profile in heavily pre-treated patients with relapsed or refractory mantle cell lymphoma.